How effective are the COVID-19 vaccines for those who are immunocompromised?

0

Up to 5000 immunocompromised people from across the UK are set to be vaccinated as part of the Octave study to investigate COVID-19 vaccine efficacy in those with impaired immune systems. 

Thus far with the UK’s COVID-19 vaccine rollout, there have been some promising results seen in trials and real-life data, with a study into the effect of a first dose of COVID-19 vaccines on the Scottish population demonstrating 85% and 94% reduced risks of hospitalization for the Pfizer–BioNTech and University of Oxford–AstraZeneca vaccines, respectively.

READ MORE ON BIOTECHNIQUES NOW

Share:

Leave A Comment